Mandate

Vinge advises J.P. Morgan, Nordea and SEB Enskilda in connection with SAS rights issue

February 09, 2010

Vinge is advising J.P Morgan, Nordea and SEB Enskilda in connection with SAS AB’s new issue of ordinary shares for approximately SEK 5 billion with pre-emption rights for the company’s existing shareholders. J.P. Morgan, Nordea and SEB Enskilda which are acting as Joint Global Co-ordinators, Joint Lead Managers and Joint Bookrunners in the rights issue have, together with DnB NOR Markets, the Royal Bank of Scotland and Danske Markets, confirmed their willingness, subject to certain conditions, to severally enter into underwriting agreements in respect of 42.4 per cent of the shares in the issue.

SAS AB is listed on NASDAQ OMX Stockholm, NASDAQ OMX Copenhagen and Oslo Børs.

Vinge’s team primarily consisted of partners Göran Nyström, Rikard Stenberg and Lennart Larsson together with associates Johan Thiman, Johan Norström and Mårten Svensson.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026